Experimental drug could boost therapy against colorectal, lung, and other cancers

  • Researchers have identified a new radioactive substance called CB-2PA-NT as a promising candidate for a theranostics strategy, combining therapy and diagnostics.
  • The substance, which targets neurotensin receptors found in various cancers, demonstrates high uptake and retention in tumors while maintaining a clear distinction from surrounding tissues.
  • With regulatory approval pending, researchers hope to conduct human imaging studies using CB-2PA-NT in the near future, which could impact personalized medicine for cancer patients.

By Paul Ian Cross, PhD on July 4, 2023 — Fact checked by Hannah Flynn

read full article

Call us at (888)-243-6602 to discuss how we can help keep your loved one safe and happy at home.